Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 12, 2016 Filed May 16, 2016 21:03 UTC |
TAI JACKSON PDirector
|
GiftCommon Stock | 1,080 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000368 · wf-form4_146343258599773.xml · nonDerivative · entry 2 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,520 Read SEC document |
| May 12, 2016 Filed May 16, 2016 21:03 UTC |
TAI JACKSON PDirector
|
PurchaseCommon Stock | 1,080 | $75.75 | $81,810.00 |
DisclosureSEC source: 0000059478-16-000368 · wf-form4_146343258599773.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,600 F1 · price: This transaction was executed in multiple trades at prices ranging from $75.74 to $75.78. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 11, 2016 Filed Jan 27, 2017 16:37 UTC |
LECHLEITER JOHN CDirector
|
GiftCommon Stock | 700 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000010 · wf-form5_148553501798236.xml · nonDerivative · entry 3 LECHLEITER JOHN C · CIK 0001209281 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 741,118 Read SEC document |
| May 10, 2016 Filed Jan 27, 2017 16:37 UTC |
LECHLEITER JOHN CDirector
|
GiftCommon Stock | 8,690 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000010 · wf-form5_148553501798236.xml · nonDerivative · entry 2 LECHLEITER JOHN C · CIK 0001209281 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 741,818 Read SEC document |
| May 09, 2016 Filed Jan 27, 2017 16:37 UTC |
LECHLEITER JOHN CDirector
|
GiftCommon Stock | 680 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000010 · wf-form5_148553501798236.xml · nonDerivative · entry 1 LECHLEITER JOHN C · CIK 0001209281 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750,508 Read SEC document |
| May 02, 2016 Filed May 3, 2016 20:36 UTC |
Zakrowski Donald AChief Accounting Officer
|
SaleCommon Stock | 600 | $76.53 | $45,918.00 |
DisclosureSEC source: 0000059478-16-000359 · wf-form4_146230779782070.xml · nonDerivative · entry 2 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,513 Read SEC document |
| April 29, 2016 Filed May 2, 2016 20:00 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 201 | $76.10 | $15,296.10 |
DisclosureSEC source: 0001209191-16-116721 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,480,804 F2 · price: The price reported in Column 4 is a weighted average price of $76.100. These shares were sold in multiple transactions at prices ranging from $76.10 to $76.11, inclusive. Read SEC document |
| April 29, 2016 Filed May 2, 2016 20:00 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 179,799 | $75.44 | $13,564,755.76 |
DisclosureSEC source: 0001209191-16-116721 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,481,005 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.10 to $76.09, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| April 29, 2016 Filed May 3, 2016 20:32 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 128 | $77.22 | $9,884.16 |
DisclosureSEC source: 0000059478-16-000355 · wf-form4_146230753363608.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,298 Read SEC document |
| April 29, 2016 Filed May 3, 2016 20:34 UTC |
MARRAM ELLEN RDirector
|
GrantCommon Stock | 85 | $77.22 | $6,563.70 |
DisclosureSEC source: 0000059478-16-000357 · wf-form4_146230767008427.xml · nonDerivative · entry 1 MARRAM ELLEN R · CIK 0001234124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,508 Read SEC document |
| April 29, 2016 Filed May 3, 2016 20:36 UTC |
Zakrowski Donald AChief Accounting Officer
|
SaleCommon Stock | 1,000 | $75.45 | $75,450.00 |
DisclosureSEC source: 0000059478-16-000359 · wf-form4_146230779782070.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,113 F1 · balance_after: Since the date of the reporting persons last ownership report, he transferred 1,736 shares of common stock to his ex-wife pursuant to a domestic relations order. Read SEC document |
| April 27, 2016 Filed Apr 28, 2016 19:43 UTC |
Zulueta Alfonso GSVP& Pres., Emerging Markets
|
SaleCommon Stock | 12,000 | $76.27 | $915,240.00 |
DisclosureSEC source: 0000059478-16-000348 · wf-form4_146187262036158.xml · nonDerivative · entry 1 Zulueta Alfonso G · CIK 0001596336 · SVP& Pres., Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,101 F1 · price: This transaction was executed in multiple trades at prices ranging from $76.25 to $76.33. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 08, 2016 Filed Apr 11, 2016 19:07 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 200,000 | $74.29 | $14,857,800.00 |
DisclosureSEC source: 0001209191-16-113848 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,660,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.89 to $74.73, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| March 31, 2016 Filed Mar 31, 2016 17:46 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 141 | $70.25 | $9,905.25 |
DisclosureSEC source: 0000059478-16-000333 · wf-form4_145944638663036.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,170 Read SEC document |
| March 31, 2016 Filed Mar 31, 2016 17:48 UTC |
MARRAM ELLEN RDirector
|
GrantCommon Stock | 94 | $70.25 | $6,603.50 |
DisclosureSEC source: 0000059478-16-000335 · wf-form4_145944651204891.xml · nonDerivative · entry 1 MARRAM ELLEN R · CIK 0001234124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,423 Read SEC document |
| March 24, 2016 Filed Jan 27, 2017 17:16 UTC |
Simmons Jeffrey NSVP&Pres. Elanco Animal Health
|
GiftCommon Stock | 2,105 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000017 · wf-form5_148553737544063.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,408 Read SEC document |
| March 21, 2016 Filed Jan 27, 2017 16:47 UTC |
Rice Derica WEVP-Global Services and CFO
|
GiftCommon Stock | 78 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000012 · wf-form5_148553562181482.xml · nonDerivative · entry 4 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Indirect · by wife Disclosed balance after: 366,059 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| March 01, 2016 Filed Jan 27, 2017 16:27 UTC |
Harrington Michael JSenior VP and General Counsel
|
GiftCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000008 · wf-form5_148553445486764.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,415 Read SEC document |
| February 29, 2016 Filed Mar 1, 2016 20:31 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 135 | $73.33 | $9,899.55 |
DisclosureSEC source: 0000059478-16-000327 · wf-form4_145686427054911.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,806 Read SEC document |
| February 29, 2016 Filed Mar 1, 2016 21:04 UTC |
MARRAM ELLEN RDirector
|
GrantCommon Stock | 89 | $73.33 | $6,526.37 |
DisclosureSEC source: 0000059478-16-000329 · wf-form4_145686625029028.xml · nonDerivative · entry 1 MARRAM ELLEN R · CIK 0001234124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,003 Read SEC document |
| February 08, 2016 Filed Jan 27, 2017 16:47 UTC |
Rice Derica WEVP-Global Services and CFO
|
GiftCommon Stock | 36,931 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000012 · wf-form5_148553562181482.xml · nonDerivative · entry 3 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Indirect · by wife Disclosed balance after: 366,137 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| February 08, 2016 Filed Jan 27, 2017 16:47 UTC |
Rice Derica WEVP-Global Services and CFO
|
GiftCommon Stock | 36,931 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000012 · wf-form5_148553562181482.xml · nonDerivative · entry 1 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 05, 2016 Filed Feb 8, 2016 20:43 UTC |
Fry Stephen FSVP, HR & Diversity
|
SaleCommon Stock | 15,230 | $78.87 | $1,201,190.10 |
DisclosureSEC source: 0000059478-16-000318 · wf-form4_145496419497142.xml · nonDerivative · entry 1 Fry Stephen F · CIK 0001513324 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,690 F1 · price: This transaction was executed in multiple trades at prices ranging from $74.75 to $75.07. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 03, 2016 Filed Feb 3, 2016 18:50 UTC |
Fry Stephen FSVP, HR & Diversity
|
SaleCommon Stock | 725 | $76.46 | $55,433.50 |
DisclosureSEC source: 0000059478-16-000294 · wf-form4_145452540290650.xml · nonDerivative · entry 4 Fry Stephen F · CIK 0001513324 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,920 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2015. Read SEC document |
| February 03, 2016 Filed Feb 3, 2016 19:02 UTC |
Rice Derica WEVP-Global Services and CFO
|
SaleCommon Stock | 3,937 | $76.81 | $302,400.97 |
DisclosureSEC source: 0000059478-16-000306 · wf-form4_145452613928424.xml · nonDerivative · entry 4 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,931 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2015. F3 · price: This transaction was executed in multiple trades at prices ranging from $76.46 to $76.94. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 03, 2016 Filed Feb 3, 2016 19:04 UTC |
Ricks David ASVP and Pres, Lilly Bio-Meds
|
SaleCommon Stock | 2,460 | $76.73 | $188,755.80 |
DisclosureSEC source: 0000059478-16-000308 · wf-form4_145452625935962.xml · nonDerivative · entry 4 Ricks David A · CIK 0001538604 · SVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,403 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2015. F3 · price: This transaction was executed in multiple trades at prices ranging from $76.46 to $76.92. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:43 UTC |
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERM
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,072 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000288 · wf-form4_145452502448570.xml · derivative · entry 4 Barnes Melissa S · CIK 0001566364 · Chief Eth/Cmpl Ofcr & SVP, ERM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,072 shares Expires 2016-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:43 UTC |
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERM
|
Tax withholdingCommon Stock | 656 | $79.10 | $51,889.60 |
DisclosureSEC source: 0000059478-16-000288 · wf-form4_145452502448570.xml · nonDerivative · entry 2 Barnes Melissa S · CIK 0001566364 · Chief Eth/Cmpl Ofcr & SVP, ERM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,702 Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:43 UTC |
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERM
|
Exercise / conversionCommon Stock | 2,072 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000288 · wf-form4_145452502448570.xml · nonDerivative · entry 1 Barnes Melissa S · CIK 0001566364 · Chief Eth/Cmpl Ofcr & SVP, ERM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,358 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:46 UTC |
Conterno Enrique ASr. VP & Pres., Lilly Diabetes
|
Exercise / conversionRestricted Stock Unit · Derivative | 10,360 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000290 · wf-form4_145452516192048.xml · derivative · entry 4 Conterno Enrique A · CIK 0001476151 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,360 shares Expires 2016-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:46 UTC |
Conterno Enrique ASr. VP & Pres., Lilly Diabetes
|
Tax withholdingCommon Stock | 4,872 | $79.10 | $385,375.20 |
DisclosureSEC source: 0000059478-16-000290 · wf-form4_145452516192048.xml · nonDerivative · entry 2 Conterno Enrique A · CIK 0001476151 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,572 Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:46 UTC |
Conterno Enrique ASr. VP & Pres., Lilly Diabetes
|
Exercise / conversionCommon Stock | 10,360 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000290 · wf-form4_145452516192048.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:48 UTC |
Crowe Maria APresident, Mfg. Operations
|
Exercise / conversionRestricted Stock Unit · Derivative | 7,252 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000292 · wf-form4_145452528615129.xml · derivative · entry 3 Crowe Maria A · CIK 0001538603 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,252 shares Expires 2016-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:48 UTC |
Crowe Maria APresident, Mfg. Operations
|
Tax withholdingCommon Stock | 3,307 | $79.10 | $261,583.70 |
DisclosureSEC source: 0000059478-16-000292 · wf-form4_145452528615129.xml · nonDerivative · entry 2 Crowe Maria A · CIK 0001538603 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,504 Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:48 UTC |
Crowe Maria APresident, Mfg. Operations
|
Exercise / conversionCommon Stock | 7,252 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000292 · wf-form4_145452528615129.xml · nonDerivative · entry 1 Crowe Maria A · CIK 0001538603 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:50 UTC |
Fry Stephen FSVP, HR & Diversity
|
Exercise / conversionRestricted Stock Unit · Derivative | 7,252 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000294 · wf-form4_145452540290650.xml · derivative · entry 6 Fry Stephen F · CIK 0001513324 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,252 shares Expires 2016-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:50 UTC |
Fry Stephen FSVP, HR & Diversity
|
SaleCommon Stock | 2,412 | $78.39 | $189,076.68 |
DisclosureSEC source: 0000059478-16-000294 · wf-form4_145452540290650.xml · nonDerivative · entry 3 Fry Stephen F · CIK 0001513324 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,645 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2015. F2 · price: This transaction was executed in multiple trades at prices ranging from $78.19 to $78.65. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:50 UTC |
Fry Stephen FSVP, HR & Diversity
|
Tax withholdingCommon Stock | 3,410 | $79.10 | $269,731.00 |
DisclosureSEC source: 0000059478-16-000294 · wf-form4_145452540290650.xml · nonDerivative · entry 2 Fry Stephen F · CIK 0001513324 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,057 Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:50 UTC |
Fry Stephen FSVP, HR & Diversity
|
Exercise / conversionCommon Stock | 7,252 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000294 · wf-form4_145452540290650.xml · nonDerivative · entry 1 Fry Stephen F · CIK 0001513324 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,467 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:52 UTC |
Harrington Michael JSenior VP and General Counsel
|
Exercise / conversionRestricted Stock Unit · Derivative | 9,066 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000296 · wf-form4_145452551565193.xml · derivative · entry 4 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,066 shares Expires 2016-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:52 UTC |
Harrington Michael JSenior VP and General Counsel
|
Tax withholdingCommon Stock | 4,194 | $79.10 | $331,745.40 |
DisclosureSEC source: 0000059478-16-000296 · wf-form4_145452551565193.xml · nonDerivative · entry 2 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,915 Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:52 UTC |
Harrington Michael JSenior VP and General Counsel
|
Exercise / conversionCommon Stock | 9,066 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000296 · wf-form4_145452551565193.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,109 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:54 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 46,623 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000298 · wf-form4_145452562976610.xml · derivative · entry 7 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 46,623 shares Expires 2016-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:54 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
Tax withholdingCommon Stock | 21,923 | $79.10 | $1,734,109.30 |
DisclosureSEC source: 0000059478-16-000298 · wf-form4_145452562976610.xml · nonDerivative · entry 2 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 751,188 Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:54 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
Exercise / conversionCommon Stock | 46,623 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000298 · wf-form4_145452562976610.xml · nonDerivative · entry 1 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 773,111 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:55 UTC |
Lundberg Jan MEVP,Science&Tech and Pres. LRL
|
Exercise / conversionRestricted Stock Unit · Derivative | 15,541 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000300 · wf-form4_145452573491445.xml · derivative · entry 4 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,541 shares Expires 2016-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:55 UTC |
Lundberg Jan MEVP,Science&Tech and Pres. LRL
|
Tax withholdingCommon Stock | 7,308 | $79.10 | $578,062.80 |
DisclosureSEC source: 0000059478-16-000300 · wf-form4_145452573491445.xml · nonDerivative · entry 2 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,734 Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:55 UTC |
Lundberg Jan MEVP,Science&Tech and Pres. LRL
|
Exercise / conversionCommon Stock | 15,541 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000300 · wf-form4_145452573491445.xml · nonDerivative · entry 1 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,042 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:58 UTC |
Mahony SusanSVP & Pres., Lilly Oncology
|
Exercise / conversionRestricted Stock Unit · Derivative | 9,843 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000302 · wf-form4_145452587491047.xml · derivative · entry 6 Mahony Susan · CIK 0001463321 · SVP & Pres., Lilly Oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,843 shares Expires 2016-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:58 UTC |
Mahony SusanSVP & Pres., Lilly Oncology
|
Tax withholdingCommon Stock | 4,629 | $79.10 | $366,153.90 |
DisclosureSEC source: 0000059478-16-000302 · wf-form4_145452587491047.xml · nonDerivative · entry 2 Mahony Susan · CIK 0001463321 · SVP & Pres., Lilly Oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,895 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.